Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Cardiology|October 16, 2022
Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary vascular remodeling due to left heart disease in miceYusuke Joki, Hakuoh Konishi, Kiyoshi Takasu, et al.
Plos One|December 29, 2021
Circulating sLR11 levels predict severity of pulmonary hypertension due to left heart diseaseYusuke Joki, Hakuoh Konishi, Hiroyuki Ebinuma, et al.
Circulation Research|March 4, 2026
Parathyroid Hormone Contributes to Pulmonary Hypertension in Hypoxic ConditionsYusuke Joki, Hakuoh Konishi, Kiyoshi Takasu, et al.
Internal Medicine (Tokyo, Japan)|March 2, 2013
Japanese features of native valve endocarditis caused by coagulase-negative staphylococci: case reports and a literature reviewYuji Nishizaki, Shinichiro Yamagami, Yusuke Joki, et al.
Internal Medicine (Tokyo, Japan)|September 15, 2012
Red blood cell distribution width as an effective tool for detecting fatal heart failure in super-elderly patientsYuji Nishizaki, Shinichiro Yamagami, Hikaru Suzuki, et al.
Respiratory Investigation|December 24, 2023
Prognostic analysis of pulmonary hypertension with lung parenchymal lesion: Comparison of mortality with and without connective tissue diseaseYoshifumi Suzuki, Tetsutaro Nagaoka, Yuriko Terayama, et al.
Nature Aging|May 30, 2024
SGLT2 inhibition eliminates senescent cells and alleviates pathological agingGoro Katsuumi, Ippei Shimizu, Masayoshi Suda, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 14, 2012
Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formationYusuke Uemura, Rei Shibata, Koji Ohashi, et al.
Journal of Molecular and Cellular Cardiology|December 6, 2014
Omentin functions to attenuate cardiac hypertrophic responseKazuhiro Matsuo, Rei Shibata, Koji Ohashi, et al.
Pageof 3